EUVIMEDOpdag EUVIMED
Open access

Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes

Alessandra Vultaggio, Matteo Accinno, Emanuele Vivarelli, Maria Elena Milanese, Michael Diomaiuti, Gennaro Illiano, Pietro Orlando iD, Annarita Palomba, Carlo Ammatuna, Lorenzo Cosmi, Oliviero Rossi, Enrico Maggi and 2 more

Clinical & Experimental Allergy · 2026-08 · 56 (8) · 920-922

DOI: 10.1111/cea.70309 ↗

At a glance

Journal article in Clinical & Experimental Allergy, published online on 2026-04-17. Written by Alessandra Vultaggio and 13 co-authors. Institution: Immunoallergology Unit, Careggi University Hospital, Florence, Italy. Cited 1 times so far (Crossref); 10 references. The full text is freely available in PubMed Central. Funded by: National Ministry of University and Research.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Dupilumab reduces tissue eosinophils in nasal polyps beyond improving clinical and endoscopic outcomes. Dupilumab treatment is associated with a reduction of tissue inflammatory eosinophils that correlates with higher clinical and endoscopic improvement.

Authors and institutions

  • Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Otolaryngology Clinic, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Department of Pathology, Careggi University Hospital, Florence, Italy.

ORCID profiles: Pietro Orlando, Andrea Matucci

Funding

  • National Ministry of University and Research

Cite

APA

Vultaggio, A., Accinno, M., Vivarelli, E., Milanese, M. E., Diomaiuti, M., Illiano, G., Orlando, P., Palomba, A., Ammatuna, C., Cosmi, L., Rossi, O., Maggi, E., Maggiore, G., & Matucci, A. (2026). Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes. Clinical & Experimental Allergy, 56(8), 920-922. https://doi.org/10.1111/cea.70309

Vancouver

Vultaggio A, Accinno M, Vivarelli E, Milanese ME, Diomaiuti M, Illiano G, et al. Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes. Clinical & Experimental Allergy. 2026;56(8):920-922. doi:10.1111/cea.70309

BibTeX
@article{Vultaggio2026,
  author = {Vultaggio, Alessandra and Accinno, Matteo and Vivarelli, Emanuele and Milanese, Maria Elena and Diomaiuti, Michael and Illiano, Gennaro and Orlando, Pietro and Palomba, Annarita and Ammatuna, Carlo and Cosmi, Lorenzo and Rossi, Oliviero and Maggi, Enrico and Maggiore, Giandomenico and Matucci, Andrea},
  title = {Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes},
  journal = {Clinical & Experimental Allergy},
  year = {2026},
  volume = {56},
  number = {8},
  pages = {920--922},
  doi = {10.1111/cea.70309}
}
Start for free →